We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $269.51, marking a -0.33% move from the previous day. This change lagged the S&P 500's daily gain of 0.18%. Meanwhile, the Dow gained 0.24%, and the Nasdaq, a tech-heavy index, added 0.03%.
Coming into today, shares of the largest U.S. health insurer had gained 1.78% in the past month. In that same time, the Medical sector gained 3%, while the S&P 500 gained 4.28%.
UNH will be looking to display strength as it nears its next earnings release. In that report, analysts expect UNH to post earnings of $3.58 per share. This would mark year-over-year growth of 17.76%. Our most recent consensus estimate is calling for quarterly revenue of $59.66 billion, up 8.11% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $14.62 per share and revenue of $244.23 billion. These results would represent year-over-year changes of +13.51% and +7.95%, respectively.
Investors might also notice recent changes to analyst estimates for UNH. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.02% higher. UNH is currently a Zacks Rank #2 (Buy).
Investors should also note UNH's current valuation metrics, including its Forward P/E ratio of 18.5. Its industry sports an average Forward P/E of 15.88, so we one might conclude that UNH is trading at a premium comparatively.
We can also see that UNH currently has a PEG ratio of 1.38. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.2 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 13, putting it in the top 6% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $269.51, marking a -0.33% move from the previous day. This change lagged the S&P 500's daily gain of 0.18%. Meanwhile, the Dow gained 0.24%, and the Nasdaq, a tech-heavy index, added 0.03%.
Coming into today, shares of the largest U.S. health insurer had gained 1.78% in the past month. In that same time, the Medical sector gained 3%, while the S&P 500 gained 4.28%.
UNH will be looking to display strength as it nears its next earnings release. In that report, analysts expect UNH to post earnings of $3.58 per share. This would mark year-over-year growth of 17.76%. Our most recent consensus estimate is calling for quarterly revenue of $59.66 billion, up 8.11% from the year-ago period.
UNH's full-year Zacks Consensus Estimates are calling for earnings of $14.62 per share and revenue of $244.23 billion. These results would represent year-over-year changes of +13.51% and +7.95%, respectively.
Investors might also notice recent changes to analyst estimates for UNH. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.02% higher. UNH is currently a Zacks Rank #2 (Buy).
Investors should also note UNH's current valuation metrics, including its Forward P/E ratio of 18.5. Its industry sports an average Forward P/E of 15.88, so we one might conclude that UNH is trading at a premium comparatively.
We can also see that UNH currently has a PEG ratio of 1.38. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.2 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 13, putting it in the top 6% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.